DNA amplification tests at universal pre-admission screening with enhanced precaution strategies for asymptomatic patients with COVID-19.
Admission
COVID-19
NAATs
Universal screening
Journal
IJID regions
ISSN: 2772-7076
Titre abrégé: IJID Reg
Pays: England
ID NLM: 9918418183106676
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
received:
11
10
2022
revised:
22
12
2022
accepted:
23
12
2022
pubmed:
10
1
2023
medline:
10
1
2023
entrez:
9
1
2023
Statut:
ppublish
Résumé
To analyse the effect of hospital pre-admission screening and enhanced precaution strategies on the transmission of severe acute respiratory syndrome coronavirus-2. This retrospective cohort study was conducted over 17 months from 11 May 2020 to 30 September 2021 at a large hospital in Tokyo. Universal DNA amplification tests were conducted during pre-admission screening, and enhanced precaution strategies were implemented for all patients with negative admission tests. The primary outcome was the occurrence of symptomatic coronavirus disease 2019 (COVID-19) in patients after admission. The secondary outcomes were time-series analyses of monthly positive admission test numbers, positive rates, clinical features in positive cases, and clinically confirmed nosocomial transmission. In total, 32,081 patients were screened pre-admission (29,556 asymptomatic patients and 2525 symptomatic patients). Of the asymptomatic patients, 0.11% ( Pre-admission test screening was effective in identifying asymptomatic cases of COVID-19. This allowed administrators to quarantine patients or delay hospital admission. The combination of testing and enhanced precaution strategies for asymptomatic cases of COVID-19 may minimize nosocomial transmission.
Identifiants
pubmed: 36618878
doi: 10.1016/j.ijregi.2022.12.010
pii: S2772-7076(22)00157-6
pmc: PMC9803604
doi:
Types de publication
Journal Article
Langues
eng
Pagination
6-10Informations de copyright
© 2022 The Author(s).
Déclaration de conflit d'intérêts
None declared.
Références
J Hosp Infect. 2021 Aug;114:167-170
pubmed: 33940091
J Perinat Med. 2020 Nov 26;48(9):981-984
pubmed: 32681783
Clin Infect Dis. 2021 Nov 2;73(9):e3127-e3129
pubmed: 33570097
JAMA Netw Open. 2021 Jan 4;4(1):e2035057
pubmed: 33410879
Clin Microbiol Infect. 2022 Feb;28(2):178-189
pubmed: 34757116
Clin Microbiol Infect. 2021 Apr;27(4):658-659
pubmed: 33221431
J Clin Virol. 2021 Sep;142:104915
pubmed: 34315009
Viruses. 2021 Apr 30;13(5):
pubmed: 33946201
Emerg Infect Dis. 2021 Feb;27(2):404-410
pubmed: 33395382
Int J Gynaecol Obstet. 2020 Aug;150(2):268-269
pubmed: 32496574
J Bone Joint Surg Am. 2020 Aug 19;102(16):1379-1388
pubmed: 32516279
Infect Control Hosp Epidemiol. 2020 Sep;41(9):1075-1076
pubmed: 32456720
Clin Infect Dis. 2021 Nov 2;73(9):e3013-e3018
pubmed: 33090210
Birth. 2021 Mar;48(1):96-103
pubmed: 33263210
Lancet Infect Dis. 2020 Dec;20(12):1381-1389
pubmed: 32822577
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):472-476
pubmed: 32298249
Emerg Infect Dis. 2021 Apr;27(4):
pubmed: 33600301